Lu Qi
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
- RNA Interference and Gene Delivery
Papers in
-
- RNA modifications and cancer 7
- Circular RNAs in diseases 5
- Epigenetics and DNA Methylation 4
-
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 6
- Co-authors
- Yanqing Ding (9 shared papers)Jin Sun (8 shared papers)Kaiyuan Wang (7 shared papers)Hao Ye (7 shared papers)Zhonggui He (6 shared papers)Wenting Liao (4 shared papers)Jian Zhao (5 shared papers)Tingting Li (2 shared papers)
- Journals
- Journal of Controlled Release (2 papers)Cancer Research (2 papers)Cell Death and Disease (2 papers)Science China Life Sciences (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Lu Qi
48 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 93
- Cancer Research 439
- Molecular Biology 720
- Immunology 175
- Oncology 223
- Physiology 29
Countries citing papers authored by Lu Qi
This map shows the geographic impact of Lu Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Qi more than expected).
Fields of papers citing papers by Lu Qi
This network shows the impact of papers produced by Lu Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Qi. The network helps show where Lu Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 125 | |
| 2 | 2020 | 106 | |
| 3 | 2013 | 99 | |
| 4 | 2017 | 74 | |
| 5 | 2017 | 61 | |
| 6 | 2023 | 52 | |
| 7 | 2020 | 51 | |
| 8 | 2022 | 49 | |
| 9 | 2021 | 42 | |
| 10 | 2021 | 41 | |
| 11 | 2022 | 35 | |
| 12 | PABPC1 exerts carcinogenesis in gastric carcinoma by targeting miR-34c. | 2015 | 30 |
| 13 | 2019 | 29 | |
| 14 | 2021 | 26 | |
| 15 | 2022 | 25 | |
| 16 | 2013 | 20 | |
| 17 | 2023 | 19 | |
| 18 | 2017 | 14 | |
| 19 | 2018 | 13 | |
| 20 | 2018 | 13 |
About Lu Qi
Lu Qi is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 52 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), Immunotherapy and Immune Responses (7 papers), RNA modifications and cancer (7 papers), Ferroptosis and cancer prognosis (7 papers), MicroRNA in disease regulation (6 papers), Nanoplatforms for cancer theranostics (5 papers), Circular RNAs in diseases (5 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (439 citations), Molecular Biology (720 citations), Immunology (175 citations), Oncology (223 citations) and Physiology (29 citations). Lu Qi has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Yanqing Ding, Yanqing Ding, Jin Sun, Kaiyuan Wang, Hao Ye, Zhonggui He, Wenting Liao, Jian Zhao, Tingting Li and Haotian Zhang. Their work appears in journals such as Journal of Controlled Release, Cancer Research, Cell Death and Disease, Science China Life Sciences and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.